Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOCILIZUMAB-AAZG vs TOFERSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOCILIZUMAB-AAZG vs TOFERSEN: Safety Overview

Metric TOCILIZUMAB-AAZG TOFERSEN
Total FAERS Reports 155 366
Deaths Reported 7 60
Death Rate 4.5% 16.4%
Hospitalizations 44 97
Average Patient Age 63.6 yrs 56.9 yrs
% Female Patients 81.3% 48.3%
FDA Approval Date N/A Apr 25, 2023
Manufacturer N/A Biogen Inc.
Route N/A INTRATHECAL
Marketing Status Prescription Prescription